Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial.

Daniel H Solomon Demler V Olga Pamela M Rist Leah M Santacroce Ahmed Tawakol Jon T Giles Katherine P LiaoJoan M Bathon

Published in: Journal of the American Heart Association (2024)

A candidate biomarker approach identified several promising biomarkers that associate with baseline and treatment-associated changes in arterial inflammation in patients with RA. These will now be tested in an external validation cohort.

Keyphrases

oxidative stress
rheumatoid arthritis
study protocol
clinical trial
phase iii
phase ii
disease activity
combination therapy
systemic lupus erythematosus
ankylosing spondylitis
open label
idiopathic pulmonary fibrosis